Everything below concerns lyophilised powder. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-03-09. Where a claim depends on a specific study, the study is described rather than over-claimed.
Purity assessment relies mainly on reversed-phase high-performance liquid chromatography, which separates the target heptapeptide from truncated sequences, deletion analogues, and oxidised forms. Mass spectrometry, usually coupled to liquid chromatography, confirms identity through the expected molecular ion and reveals modifications such as methionine sulfoxide formation. Amino acid analysis can verify composition, and tandem mass spectrometry supports sequence confirmation. Ultraviolet detection near 254 to 280 nanometres is convenient because the phenylalanine and histidine residues absorb in that region. Nuclear magnetic resonance is rarely used for routine release testing.
Common degradation pathways include oxidation of the methionine side chain, hydrolysis of the peptide backbone, and aggregation under unfavourable pH or concentration. Stability studies typically monitor the main peak by chromatography and report total related substances as a percentage. Because no official monograph exists, acceptance criteria vary between laboratories, and reported purity values are not directly comparable across suppliers. Analysts therefore document the method, column, and detection wavelength alongside each result, and open questions remain about how much biological activity the oxidised forms retain.
Development is attributed to researchers at the Institute of Molecular Genetics in Moscow during the early 1980s, building on earlier Soviet work with ACTH fragments. Russian regulatory approval followed for intranasal use, and the compound has remained commercially available there for decades. Most published human data originate from Russian and, later, some Eastern European clinical reports, which are not always accessible in English translation. Outside that region the material is generally handled as a research chemical rather than a licensed medicine.
Regulatory status differs sharply between jurisdictions. In Russia the peptide is registered as a prescription nasal preparation, while agencies such as the United States Food and Drug Administration have not approved it for any indication. Products sold elsewhere are typically labeled for laboratory research only, and such labels shift responsibility for safe handling to the purchaser. Because the same name covers pharmaceutical-grade nasal drops and bulk research powder, identity and purity documentation becomes the main practical concern when comparing sources.
| Property | Value | Notes |
|---|---|---|
| Typical analytical method | Reversed-phase HPLC with UV detection | Separates target peptide from truncated and oxidised forms |
| Identity confirmation | LC-MS or ESI-MS | Compares observed and calculated molecular ion |
| Primary degradation route | Methionine oxidation | Forms the sulfoxide; monitored as an early-eluting peak |
| Short-term storage | 2 to 8 degrees Celsius | Applies to working vials and reconstituted portions |
| Common synonyms | ACTH(4–10) analogue, MEHFPGP | Descriptive names used in laboratory catalogues |
The mechanisms attributed to semax are inferred from animal and cell studies rather than traced to one confirmed target. The most frequently cited pathway involves increased expression of brain-derived neurotrophic factor and nerve growth factor in hippocampal and cortical tissue. Some work points to engagement of melanocortin receptors, particularly MC4, which the parent ACTH fragment can activate. Effects on dopaminergic and serotonergic signalling have also been reported. No single account explains all observed results, and the relative weight of each pathway remains unsettled.
Published studies examine a fairly narrow set of endpoints. Rodent experiments commonly measure maze learning, infarct volume after induced ischemia, and tissue levels of neurotrophic factors. Clinical reports from Russian centres describe attention, memory and recovery scores in patients after stroke or transient ischemic attack. Most of those human studies are small and few have been repeated by independent groups. Outcome measures differ between studies, which limits direct comparison.
Semax is a synthetic heptapeptide whose sequence is Met-Glu-His-Phe-Pro-Gly-Pro. The first four residues correspond to the ACTH(4-10) fragment, while the terminal Pro-Gly-Pro extension was added to improve metabolic stability. Its molecular formula is C37H51N9O10S and its monoisotopic mass is approximately 813.9 Da. The compound is classified as a peptide research chemical and as a registered pharmaceutical product in Russia, but it does not hold marketing approval in the European Union or the United States. Naming conventions vary across supplier catalogs.
Development of the compound took place in the Soviet Union during the 1980s, largely through peptide research groups affiliated with the Shemyakin-Ovchinnikov Institute and Moscow State University. Investigators screened fragments of adrenocorticotropic hormone for activity on the central nervous system while attempting to separate cognitive effects from hormonal ones. The shortened sequence was selected because it retained behavioral activity in animal models without stimulating corticosteroid release. Early publications described the molecule as an ACTH(4-10) analog.
Published research on this peptide originates mainly from Russian laboratories, and the wider international literature is comparatively thin. Studies have used rodent models of stroke, hypoxia, and memory tasks, with a smaller number of human trials reported. Reported outcomes include changes in attention and memory measures, along with effects on neurotrophic factor expression in some experiments. Small sample sizes, inconsistent dosing protocols, and limited independent replication are widely noted limitations, so the strength of the clinical evidence remains an open question.
Identity and purity are commonly assessed by reversed-phase high-performance liquid chromatography, with ultraviolet detection near 214 nanometers for the peptide backbone. Mass spectrometry, either electrospray or matrix-assisted laser desorption, confirms molecular mass and detects truncation or modification products. Amino acid analysis can verify composition. Because the sequence contains no strongly absorbing aromatic residue apart from phenylalanine, detection wavelengths are chosen carefully. Purity values above 95 percent are typical for research-grade material.
Quality documentation for research-grade peptide usually includes a certificate of analysis stating purity, identity, and residual counterion content. Batch-to-batch variation in purity and salt form is a recognized issue, and comparisons across suppliers require attention to the exact counterion, for example acetate versus trifluoroacetate. Sequence verification by tandem mass spectrometry provides stronger evidence than a single mass measurement. For any study reporting biological results, the analytical method and the measured purity should be stated explicitly. Independent verification of supplier claims is considered good practice.
Later generations of the molecule include an N-acetylated form and an amidated form, both marketed online alongside the parent peptide. These variants differ in terminal chemistry and stability, and they are frequently discussed in the same breath even though they have not been compared in controlled trials. Supply outside formal healthcare systems comes largely from laboratories that synthesize peptides to order. Purity and identity of these materials vary widely, and no single body oversees the international trade.
Semax is a synthetic heptapeptide developed in the Soviet Union during the 1980s by researchers at the Institute of Molecular Genetics in Moscow. It was designed as a truncated analog of adrenocorticotropic hormone, retaining only the fragment spanning residues four through ten. Investigators sought a peptide that would preserve the cognitive effects associated with ACTH while eliminating the hormonal stimulation of the adrenal cortex. The compound entered clinical use in Russia during the following decade.
Russian regulatory authorities approved the peptide for nasal administration, and it remains listed in the national pharmacopoeia under several trade names. Documented indications include acute ischemic stroke, transient ischemic attacks, traumatic brain injury, and certain ophthalmological and neurological conditions. Physicians also prescribe it for cognitive complaints in older patients, although the evidence base for that use is thinner. Outside Russia and a few neighboring states, the substance is not an approved medicine and is sold instead as a research chemical.
Furthermore, various formal and legal issues were found in multiple restaurants, such as dirty waste buckets too close to fresh food, parts of operations done under the company ID of the parent company instead of the actual restaurant as registered with food safety authorities, and incomplete paperwork on deliveries. In September 2025, Czech journalist Jan Tuna reported that the practices of artificially extending the shelf life of meat that led to the closure of all KFC outlets in Denmark may also be used by some branches in the Czech Republic. He cited the testimony of a former employee from the Jablonec nad Nisou branch. The State Agricultural and Food Inspection Authority later revealed that similar practices were used by the KFC outlet in Liberec. The inspection subsequently decided to carry out mass inspections of KFC restaurants throughout the country. In November the spokesperson of the State Agricultural and Food Inspection Authority revealed that employees of the KFC outlet in Prague-Dejvice defrosted chicken meat in standing water, which increases microbiological risks.
Stephen B. H. Kent (born December 12, 1945, Wellington, New Zealand). Stephen Kent is best known for establishing the field of modern chemical protein synthesis. At The Scripps Research Institute in the early 1990s he introduced the chemical ligation concept: condensation of unprotected peptides, for the total synthesis of protein molecules. With his student Philip Dawson, he developed the native chemical ligation reaction for the covalent condensation of unprotected peptide chains linked by native peptide bonds Kent pioneered the study of mirror image protein molecules. His laboratory experimentally demonstrated that chemical synthesis of a protein's polypeptide chain using mirror-image D-amino acids, after folding results in a mirror-image D-protein molecule which, if the D-protein is an enzyme, will catalyze a chemical reaction with mirror-image stereospecificity. Kent was the inventor of mirror image drug discovery, the use of mirror image protein targets to discover novel chiral drug leads, and his laboratory pioneered the systematic development of D-protein molecules as candidate therapeutics. At the University of Chicago, Kent and his junior colleagues pioneered the elucidation of novel protein structures by quasi-racemic & racemic crystallography .
On 1 April 1974, Powys was created under the Local Government Act 1972. At first, the former administrative counties of Montgomery, Radnor, and Brecknock were districts within it. On 1 April 1996, the districts were abolished, and Powys was reconstituted as a unitary authority. There was a minor border adjustment in the northeast—specifically, the addition of the communities of Llansilin and Llangedwyn from Glyndŵr district in Clwyd—and with moving the border, so that rather than half of Llanrhaeadr-ym-Mochnant, all is included. The first Lord Lieutenant of Powys was previously the Lord Lieutenant of Montgomeryshire. The Lord Lieutenant of Brecknockshire and Lord Lieutenant of Radnorshire were appointed as lieutenants. The present lord lieutenant is Shân Legge-Bourke of Crickhowell.
President Donald Trump has stated the goals of the war were to destroy Iran's ballistic missiles, eliminate their navy, prevent them from acquiring nuclear weapons, and to stop Iranian proxies from holding power. Trump asserted that Iran's ballistic missile program could endanger US allies "throughout the world", including Europe and American mainland. Pete Hegseth said that Iran would be capable of nuclear blackmail with their ballistic missiles if the US did not attack it. However, a Defense Intelligence Agency assessment determined that Iran would not be capable of building intercontinental ballistic missiles until 2035. Secretary of State Marco Rubio warned that Iran posed an "imminent threat" to US bases in the event of Israeli strikes on Iran, thereby portraying the war as a preemptive one. Mike Johnson, the Speaker of the United States House of Representatives and Rubio said that Israel was going to attack Iran, after which Iran's retaliations against US bases would have brought them into war anyway. Senator Mark Warner of the Senate Intelligence Committee who was briefed by Rubio before the war began said that there was no evidence that Iran was going to launch a pre-emptive strike against the US, and that the war was ultimately decided upon by Israel. Trump rejected these claims, stating that "I might have forced their hands.
Sources: en.wikipedia.org
==== Pain circuitry ==== The outcome of NOP activation on the brain's pain circuitry is site-specific. Within the central nervous system its action can be either similar or opposite to those of opioids depending on their location. In animal models, activation of NOP in the brain stem and higher brain regions has mixed action, resulting in overall anti-opioid activity. NOP activation at the spinal cord and peripheral nervous system results in morphine-comparable analgesia in non-human primates.
The 1982–83 Football League Trophy was the second edition of the Football League Group Cup, which had been renamed the Football League Trophy. It was won by Millwall, who beat Lincoln City 3–1 in the final at Sincil Bank. Next season the tournament would be reconstituted as the Associate Members' Cup which runs as the EFL Trophy today.
March 21: Adoption of the Civil Code ("Napoleonic Code"), institutionalizing women's legal inferiority and mandating obedience to husbands. May 18: Imperial Constitution (Organic Senatus-Consultum of 28 Floréal Year XII) establishes the First Empire, maintaining monarchy-era crown succession laws.
Sources: en.wikipedia.org
Dry powder is usually kept at about -20 degrees Celsius for long-term storage and at 2 to 8 degrees Celsius for short working periods. Containers should stay sealed and protected from light and moisture to limit degradation.
Oxidation of the methionine residue to the sulfoxide is a frequently reported change, and it usually appears as an earlier-eluting peak in reversed-phase chromatography. Backbone hydrolysis products can also accumulate in aqueous solution.
Liquid chromatography coupled with mass spectrometry is the usual approach, because the observed molecular ion can be compared with a calculated mass of about 813.9 Da. Retention time alone does not establish identity.
It is a short synthetic peptide built from seven amino acids: methionine, glutamic acid, histidine, phenylalanine and three prolines. The sequence derives from the 4-10 fragment of adrenocorticotropic hormone with an added proline-glycine-proline tail. No plant or animal extract is involved; the material is produced by solid-phase peptide synthesis.